TAL
PACB icon

TIG Advisors LLC’s Pacific Biosciences PACB Stock Holding History

TIG Advisors LLC’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-99,930
Closed -$516K – 55
2019
Q3 		$516K Sell
99,930
-199,118
-67% -$1.11M 0.02% 48
2019
Q2 		$1.81M Buy
+299,048
New +$2.1M 0.07% 46

Other funds holding PACB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
WIC
Water Island Capital New York $1.08B AUM 105.75% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

TIG Advisors LLC's PACB Position: Q4 2019 in Review

TIG Advisors LLC sold out of Pacific Biosciences (PACB) in Q4 2019, closing a stake of 99,930 shares — an estimated $516K sold.

TIG Advisors LLC first reported a position in PACB in Q2 2019 and held it in 2 quarters. The position peaked at $1.81M in Q2 2019. 143 funds tracked by Wall St. Rank hold PACB as of Q4 2019.

  • TIG Advisors LLC reported no remaining Pacific Biosciences position as of Q4 2019 after selling out during the quarter.
  • TIG Advisors LLC sold 99,930 Pacific Biosciences shares in Q4 2019, an estimated $516K.
  • TIG Advisors LLC first reported a position in Pacific Biosciences in Q2 2019 and held it in 2 quarters.
  • TIG Advisors LLC's Pacific Biosciences position peaked at $1.81M in Q2 2019.
  • 143 funds tracked by Wall St. Rank held Pacific Biosciences as of Q4 2019.

Based on TIG Advisors LLC's 13F filing for Q4 2019, filed 14 Feb 2020.